Table 3 Tractional retinal detachment characteristics following injection of Ranibizumab 1 and 3 days prior to diabetic vitrectomy
Time point | Group A | Group B | Group C | |||
|---|---|---|---|---|---|---|
Baseline | 3 days | Baseline | 1 days | Baseline | 3 days | |
TRD characteristics from ultrasound | ||||||
Number of eyes with TRD | 13(81.25%) | 13(81.25%) | 12(75%) | 12(75%) | 11(68.75%) | 11(68.75%) |
Number of eyes with macula TRD | 9(56.25%) | 9(56.25%) | 7(43.75%) | 7(43.75%) | 7(43.75%) | 7(43.75%) |
Dimensions of TRD (mean (SD)) | ||||||
Height (mm) | 2.1 (1.7) | 2.2 (1.7) | 1.9 (1.7) | 1.8 (1.7) | 2.1 (1.6) | 2.3 (1.9) |
Base (mm) | 6.7(5.4) × 6.8(5.1) | 7.0(5.9) × 6.8(5.1) | 7.4(5.3) × 6.3(4.7) | 7.4(5.5) × 5.7(4.1) | 8.2(5.0) × 8.5(5.3) | 8.4(5.2) × 8.7(5.3) |
Intraoperative TRD | ||||||
Absent | 3 | 2 | 3 | |||
Hammock | 4 | 4 | 2 | |||
Diffuse central | 3 | 3 | 3 | |||
Tabletop | 3 | 3 | 3 | |||